Posts Tagged ‘liraglutide’
Non-Insulin management of geriatric patients having Type 2 Diabetes Mellitus: A Review
Posted by: admin on: January 27, 2012
With India becoming the diabetic capital we need to know how to manage our elderly diabetic patients. Choice of hypoglycemic agents in geriatric patients needs to be individualized says a review. Team@CMHF
Liraglutide for the Treatment of Type 2 Diabetes: A Clinical Update
Posted by: admin on: December 13, 2011
Compared to other hypoglycemic GLP-1 analogs, injectable liraglutide marketed by Novo Nordisk has reiterated its position as an efficient and safe post prandial glycemic level controller. Here is the study. Team@CMHF
FDA Warns of Serious Risks Associated With Liraglutide
Posted by: admin on: December 13, 2011
Antidiabetic drug Liraglutide, reduces meal-related hyperglycemia (for 12 hours after administration) by increasing insulin secretion, delaying gastric emptying, and suppressing prandial glucagon secretion. But its safety is questionable since it is associated with pancreatitis, and increased calcitonin secretion associated with thyroid tumour in mice. Read on to know more. Team@CMHF
EASD: Once-Weekly Exenatide Flops Against Liraglutide
Posted by: admin on: November 14, 2011
Although exenatide has found to have same pharmacological actions as the GLP1 liraglutide, its weekly doses fail to reduce levels of HbA1c as much as the later. Read on to know more. Team@CMHF
An Introduction to Liraglutide
Posted by: admin on: October 31, 2011
In recent years diabetes is prevailing widely and has become matter of concern. Newer and newer drugs are coming to control diabetes. Recent introduction of Liraglutide seems to be promising. Team@CMHF
Search
- drchasrani: Difficult to get such a data, authenticated at that. Try Times of India online library
- rakesh pore: hi, where can i get genuine information about "10 most common drugs sold in india?" i want it for a local project
- nilesh dutta: sir, Plz give detail about MBA Sports Management Thanks and Regards
